Haiti’s pharmaceutical landscape operates within a uniquely challenging yet highly structured donor-driven ecosystem. As one of the most aid-dependent health systems in the Western Hemisphere, Haiti’s medicine procurement is dominated by PAHO/WHO, UNICEF, global NGOs, and government tenders via the Ministry of Public Health & Population (MSPP). Despite political instability, frequent emergencies, a fragile regulatory framework, and logistics constraints, the market presents steady, repeat-volume opportunities for certified manufacturers who meet international standards and maintain timely supply capability.
As Taj Pharma, a WHO-GMP, ISO 9001:2018, and PIC/S-compliant global manufacturer with strong export capacity, we are strategically positioned to deliver high-demand essential medicines, injectables, IV fluids, emergency care kits, critical antibiotics, and specialized therapeutic products required across Haiti’s humanitarian and government channels.
| Product Name | Dosage Form | Strength | Therapeutic Category | BCS Class (Estimate) |
|---|---|---|---|---|
| Multivitamin Tablets | Tablet | — | Nutritional Supplement | BCS Class III |
| Metronidazole Tablet | Tablet | 250 mg | Antibacterial / Antiprotozoal | BCS Class I |
| Vitamin B-Complex Tablets | Tablet | — | Nutritional / Vitamin | BCS Class III |
| Cotrimoxazole Tablets | Tablet | 400 mg + 80 mg | Antibacterial | BCS Class II |
| Doxycycline Tablets | Tablet | 100 mg | Antibiotic | BCS Class I |
| Amoxicillin Tablets | Tablet | 250 mg | Antibiotic | BCS Class I |
| Phenobarbital Tablets | Tablet | 30 mg | Anticonvulsant | BCS Class I |
| Cefalexin Capsules | Capsule | 250 mg | Antibiotic | BCS Class I |
| Paracetamol Tablets | Tablet | 500 mg | Analgesic / Antipyretic | BCS Class III |
| Zinc Sulphate Dispersible Tablets | Tablet | 20 mg | Nutritional Supplement | BCS Class II |
| Ceftriaxone Injection | Injection (Vial) | 1 g | Antibiotic | BCS Class I |
| Diclofenac Injection | Injection (Ampoule) | 25 mg/mL | NSAID | BCS Class II |
| Omeprazole Injection | Injection (Vial) | 40 mg | Antiulcer / PPI | BCS Class II |
| Biperiden Tablets | Tablet | 2 mg | Antiparkinsonian | BCS Class I |
| Hydralazine HCl Injection | Injection (Vial) | 20 mg/2 mL | Antihypertensive | BCS Class I |
| Metronidazole Infusion | IV Infusion | 5 mg/mL | Antibacterial | BCS Class I |
| Loratadine Tablet | Tablet | 10 mg | Antihistamine | BCS Class II |
| Paracetamol Infusion | IV Infusion | 1 g/100 mL | Analgesic / Antipyretic | BCS Class III |
| Furosemide Injection | Injection | 10 mg/2 mL | Diuretic | BCS Class I |
| Sodium Valproate Gastro-resistant Tablets | Tablet | 200 mg | Anticonvulsant | BCS Class I |
| Clotrimazole Vaginal Tablet | Vaginal Tablet | 500 mg | Antifungal | BCS Class II |
| Dexamethasone Injection | Injection (Ampoule) | 4 mg/mL | Corticosteroid | BCS Class I |
| Gentamicin Injection | Injection (Ampoule) | 40 mg/mL | Antibiotic | BCS Class I |
| Lidocaine HCl Injection | Injection (Vial) | 2% | Local Anaesthetic | BCS Class I |
| Magnesium Sulphate Injection | Injection | 50% | Electrolyte | BCS Class I |
| Ringer Lactate Solution | IV Infusion | 1000 mL | IV Fluid | NA |
| Adrenaline Injection | Injection (Ampoule) | 1 mg/mL | Emergency Medicine | BCS Class I |
| Diazepam Injection | Injection | 10 mg/2 mL | Sedative / Anxiolytic | BCS Class II |
| Dextrose 5% | IV Infusion | 500 mL | IV Fluid | NA |
| Procaine Penicillin Injection | Injection | 3 MIU | Antibiotic | BCS Class I |
| Benzathine Penicillin Injection | Injection | 2.4 MIU | Antibiotic | BCS Class I |
| Potassium Chloride Injection | Injection | 1 g/10 mL | Electrolyte | NA |
| Tranexamic Acid Injection | Injection | 100 mg/mL | Antifibrinolytic | BCS Class I |
| Ketamine Injection | Injection | 50 mg/mL | Anaesthetic | BCS Class I |
| Phenobarbital Injection | Injection | 200 mg/mL | Anticonvulsant | BCS Class I |
| Cephazolin Injection | Injection | 1 g | Antibiotic | BCS Class I |
| Chlorpromazine Injection | Injection | 25 mg/mL | Antipsychotic | BCS Class I |
| Benzyl Penicillin Injection | Injection | 5 MIU | Antibiotic | BCS Class I |
| Calamine Lotion | Topical | 15% | Dermatological | — |
| Bupivacaine Injection | Injection | 0.5% | Anaesthetic | BCS Class I |
| Clindamycin 150 mg Capsules | Capsule | 150 mg | Antibiotic | BCS Class II |
| Ibuprofen Suspension | Oral Suspension | 100 mg/5mL | Analgesic / NSAID | BCS Class II |
| Lidocaine + Dextrose Injection | Injection | 5% + 7.5% | Anaesthetic | BCS Class I |
| Sodium Bicarbonate Injection | Injection | 8.4% | IV pH Corrective | NA |
| Heparin Injection | Injection | 5000 IU/mL | Anticoagulant | NA |
| Silver Sulfadiazine Cream | Topical | 1% | Burn / Wound Care | — |
| Insulin Isophane Injection | Injection | 100 IU/mL | Antidiabetic | NA |
| Atracurium Injection | Injection | 100 mg/5 mL | Muscle Relaxant | NA |
| Procaine Penicillin Injection | Injection | 1 MIU | Antibiotic | BCS Class I |
| Clindamycin Injection | Injection | 150 mg/mL | Antibiotic | BCS Class II |
| Dextrose + NaCl | IV Infusion | 5% + 0.9% | IV Fluid | NA |
| Halothane Inhalation | Inhalation | 250 mL | Anaesthetic | NA |
| Amikacin Injection | Injection | 100 mg/2 mL | Antibiotic | BCS Class I |
| Propofol Injection | Injection | 10 mg/mL | Anaesthetic | NA |
| Multivitamin Parenteral | Injection | 10 mL | Nutritional IV | — |
| Gentamicin Suspension | Oral Suspension | 40 mg/mL | Antibiotic | BCS Class I |
| Chlorhexidine Solution | Topical | 5% | Antiseptic | — |
Haiti’s Donor-Led Pharmaceutical Market: Structure, Buyers & Supply Priorities
1. Core Procurement Drivers in Haiti’s Health System
Haiti’s pharmaceutical demand is shaped primarily by:
- PAHO/WHO Strategic Fund & Emergency Operations
- UNICEF Supply Division
- International NGOs (Médecins Sans Frontières, Partners in Health, International Medical Corps)
- USAID-funded programs and donor-backed consortia
- MSPP national tenders for the public healthcare network
These actors procure the majority of the country’s essential medicines, vaccines, IV solutions, surgical consumables, and emergency-response supplies.
High-Demand Product Categories
Haiti’s tender ecosystem consistently requests:
- Essential antibiotics (Ceftriaxone, Ampicillin, Amoxicillin, Gentamicin – oral & injectable)
- Critical care injectables & analgesics (IV paracetamol, Ketamine, Diazepam, Adrenaline)
- IV fluids (Ringer’s Lactate, Dextrose, Normal Saline – large volume)
- Anaesthetics & emergency room medicines
- Wound and burn care products (Silver Sulfadiazine)
- Nutrition & maternal-child health formulations
- Vaccines & cold-chain pharmaceuticals
- Disaster relief kits & cholera response supplies
Because Haiti is frequently affected by natural disasters, disease outbreaks, and political disruptions, emergency procurements are common and occur throughout the year.
How Haiti Issues Tenders: Procurement Channels & Requirements
2. PAHO/WHO – Strategic Fund & Emergency Procurement
PAHO serves as one of Haiti’s most significant pharmaceutical buyers. Tender routes include:
- Annual essential medicine tenders
- Framework agreements for long-term supply
- Emergency response shipments during crises
- PAHO Strategic Reserve procurement
To participate, suppliers must meet WHO-GMP, stringent QA standards, traceability systems, and provide compliant technical dossiers.
3. UNICEF Supply Division – A Key Buyer for Haiti
UNICEF focuses heavily on:
- Maternal-child medicines
- Vaccines
- Nutritional formulations
- Anti-infectives
- Emergency kits
Suppliers must register on UNGM and pass UNICEF’s stringent qualification process. Good lead times and stable quality are essential.
4. MSPP – Government Tender Mechanism
The Ministry of Public Health & Population (MSPP) conducts:
- National essential medicines tenders
- Bulk procurement for hospitals
- Donor-funded project-specific purchases
Documentation is required in French/Creole, and many tenders require local registration or import permits.
Regulatory, Registration & Documentation Requirements in Haiti
5. Pharmaceutical Registration Essentials
To supply MSPP or local distributors, the following are required:
- Sanitary registration with MSPP
- CPP (Certificate of Pharmaceutical Product)
- WHO-GMP certificate
- Free Sale Certificate
- Product leaflet and packaging in French/Creole
- Batch-wise COA, stability statements, and test reports
UN agencies may allow WHO-prequalified or PAHO-compliant products without country registration for emergency shipments, but government tenders require full documentation.
Logistics & Delivery: Operational Realities in Haiti
6. Shipping Challenges & Mitigation Strategies
Major constraints include:
- Port-au-Prince congestion
- Cold chain limitations
- Political/security-related delays
- Warehousing shortages
Suppliers must prepare accordingly with:
- Robust packaging and moisture-resistant cartons
- Long shelf-life products (≥70% remaining)
- Temperature-controlled consignments
- Experienced Haiti freight forwarders
- Flexible routing plans
Taj Pharma’s export team is equipped to manage CIF/FOB shipments, palletized cargo, and temperature-sensitive goods.
Payment Terms, Pricing Trends & Tender Scoring
7. Haiti Tender Evaluation Parameters
UN/PAHO/UNICEF procurements score suppliers based on:
- Quality & Certifications (WHO-GMP/PIC/S/ISO)
- Competitive Pricing
- Lead Time & Production Capacity
- Packaging Compliance
- Past Performance
- Technical Documentation Accuracy
Payments are reliable via:
- UN bank transfers
- Letters of credit
- PAHO centralized payments
Government tenders may require careful financial vetting.
Risk Landscape & Mitigation Strategies
8. Key Risks
- Political instability
- Security issues impacting transportation
- Regulatory delays
- Natural disasters
- Cold-chain failures
Mitigation
- Partner with local logistics agents
- Maintain buffer stock in regional hubs
- Use PAHO’s Strategic Reserve routing
- Pre-submit dossiers to avoid delays
- Prepare multi-lingual labeling in advance
Taj Pharma’s Unmatched Competitive Strengths in Haiti’s Tender Market
9. Why Taj Pharma Fits Haiti’s Procurement Requirements Perfectly
High-Quality, WHO-GMP Certified Manufacturing
Taj Pharma’s manufacturing facility in Gujarat is:
- WHO-cGMP approved
- ISO 9001:2018 certified
- PIC/S & GLP compliant
These credentials meet UN/PAHO qualification criteria.
Extensive Portfolio Matching Haiti’s Priority Needs
Our portfolio includes:
- Broad-spectrum antibiotics
- Injectable analgesics & anaesthetics
- IV fluids
- Emergency & critical care medicines
- Pediatric and maternal formulations
- Nutritional supplements
- Wound care products
Global Export Capability
Our supply chain supports:
- Large-volume batch production
- Rapid lead times
- FOB/CIF deliveries
- French/Creole labeling support
Tender-Ready Documentation
We provide:
- TDS (Technical Data Sheets)
- COA & QC reports
- CPP, FSC, GMP certificates
- French labeling templates
- Batch traceability
Support for Registration & Local Compliance
We assist with:
- Dossier preparation
- Local agent coordination
- Sanitary registration
- MSPP documentation
Step-by-Step Strategy for Winning Haiti Pharmaceutial Tenders
10. Action Plan
- Register on UNGM, PAHO, UNICEF procurement portals
- Enroll in PAHO Strategic Fund supplier list
- Prepare French/Creole labels & artwork
- Develop tender packs for high-demand SKUs
- Initiate MSPP dossier submission for top 20 SKUs
- Engage Haiti-based logistics partners
- Reach out to PAHO Haiti with capability statement
- Respond rapidly to emergency tenders
Haiti Market Represents a High-Potential, High-Impact Opportunity for Taj Pharma
With a donor-driven procurement model, stable payment pathways, and high-volume essential medicine requirements, Haiti is a strategically valuable market for Taj Pharma’s WHO-GMP-certified portfolio. By aligning with PAHO, UNICEF, MSPP, and major NGOs, we can deliver sustainable, reliable, life-saving pharmaceutical solutions to Haiti’s fragile health ecosystem.
Through robust manufacturing quality, comprehensive tender documentation, multilingual labeling capability, and advanced export logistics, Taj Pharma is exceptionally positioned to serve Haiti’s long-term and emergency healthcare needs.






